CNS & Neurological Disorders - Drug Targets
Title:Commentary (Research Highlights: Transcranial Drug Delivery for Neurological Disorders)
Volume: 13 Issue: 3
Author(s): Ti-Fei Yuan, Sergio Machado and Oscar Arias-Carrion
Affiliation:
Export Options
About this article
Cite this article as:
Yuan Ti-Fei, Machado Sergio and Arias-Carrion Oscar, Commentary (Research Highlights: Transcranial Drug Delivery for Neurological Disorders), CNS & Neurological Disorders - Drug Targets 2014; 13 (3) . https://dx.doi.org/10.2174/187152731303140526111533
DOI https://dx.doi.org/10.2174/187152731303140526111533 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
Current Alzheimer Research Pramipexole Tachyphylaxis and its Management in Bipolar Depression
Letters in Drug Design & Discovery Simultaneous Determination of Lamotrigine, Topiramate, Oxcarbazepine, and 10,11-dihydro-10-hydroxycarbazepine in Human Blood Plasma by UHPLC-MS/MS
Current Analytical Chemistry Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance
Current Medicinal Chemistry Update on the Evaluation and Management of Brief Resolved Unexplained Events (Previously Apparent Life-Threatening Events)
Reviews on Recent Clinical Trials Population Pharmacokinetics of Levetiracetam: A Systematic Review
Current Reviews in Clinical and Experimental Pharmacology Molecular Biomarkers for Amyotrophic Lateral Sclerosis
Current Bioinformatics Ultrasonic Assisted Synthesis, Biological Evaluation, and Molecular Docking of Chalcone-based 1,5-benzodiazepine as Potential Anticonvulsant Agents
Current Enzyme Inhibition Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties
Current Alzheimer Research New Highlights in the Regulation of Cells Proliferation
Neuroscience and Biomedical Engineering (Discontinued) ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design Lessons Learned from Muscle Fatigue: Implications for Treatment of Patients with Hyperkalemic Periodic Paralysis
Recent Patents on Biotechnology Na+ Channel Pharmacology and Molecular Mechanisms of Gating
Current Pharmaceutical Design C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding
Current Genomics Controlled Somatic and Germline Copy Number Variation in the Mouse Model
Current Genomics